MolNFT v1 · #182128 · protein
7MHQ: Ensemble refinement structure of SARS-cov-2 main protease (mpro) at 310 K
7MHQ · 3C-like proteinase: “Ensemble refinement structure of SARS-cov-2 main protease (mpro) at 310 K”. X-ray diffraction, 1 ligand (ZN), 3 pockets (best druggability 0.57). MolNFT v1 #182128 on GenesisL1: 3D structure, binding sites and…

- PDB
- 7MHQ
- Type
- protein
- Length
- 306 residues
- Chains
- 1
- Method
- x-ray diffraction
- Deposited
- 15-APR-21
- Collection
- MolNFT v1 / PDB
- Contract
- 0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
- Owner
- 0x3396CDB397284571d12822B4ae1189a8E22AAAAA
- Molecule
- 3C-like proteinase
- EC
- 3.4.22.69
- UniProt
- P0DTD1
- Ligands
- ZN
- Pockets
- 3 · best druggability 0.57
Structure
x-ray diffraction · 1 distinct chain · 23% helix, 26% strand (DSSP).
| Chain | Molecule | Type | Residues | Secondary structure | UniProt |
|---|---|---|---|---|---|
| A | 3C-like proteinase (EC 3.4.22.69) | protein | 306 | 23% helix, 26% strand | P0DTD1 |
Ligands and binding sites
Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.
Pockets
3 pockets found on a 1 Å grid, 1 with a druggability of 0.5 or more.
| Volume (ų) | Druggability | Buriedness | Lining residues | Inside | |
|---|---|---|---|---|---|
| 1 | 324 | 0.57 | 0.76 | 45 | DMS |
| 2 | 138 | 0.47 | 0.78 | 23 | empty |
| 3 | 139 | 0.44 | 0.76 | 20 | empty |
Compared structures
- 7MHQ · Ensemble refinement structure of SARS-CoV-2 main protease (Mpro) at 310 K · the same entry in another collection · chain A against A, TM-score 1.00
Analyse
- Open in the research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides and crosslinks on the 3D structure
- Every structure of UniProt P0DTD1
- Elsewhere: RCSB PDB 7MHQ · PDBe 7MHQ · UniProt P0DTD1
Other records of 7MHQ
- 7MHQ · MolNFT v2 / PDB Bank · Ensemble refinement structure of SARS-CoV-2 main protease (Mpro) at 310 K
GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.